HomeInsightsPE

Gujarat Themis Biosyn Ltd PE Ratio

Gujarat Themis Biosyn Ltd PE Ratio

stocks purchased

₹ 0.3 Cr

Volume transacted

stocks purchased

7.6 K

stocks traded

Last Updated time: 19 Sep 10:31 AM

Image

Gujarat Themis Biosyn Ltd

NSE: GUJTHEMIS

PE

69.6

Last updated: 19 Sep 10:31 AM

Key Highlights

  • The P/E Ratio of Gujarat Themis Biosyn Ltd is 69.6 as of 19 Sep 10:31 AM.
  • The P/E Ratio of Gujarat Themis Biosyn Ltd changed from 8.9 on March 2019 to 9.7 on March 2024 . This represents a CAGR of 1.44% over 6 years. .
  • The Latest Trading Price of Gujarat Themis Biosyn Ltd is ₹ 347.05 as of 19 Sep 10:25.
  • The PE Ratio of Pharmaceuticals Industry has changed from 28.2 to 27.1 in 5 years. This represents a CAGR of -0.79%.
  • The PE Ratio of Automobile industry is 21.8. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.2. The PE Ratio of Pharmaceuticals industry is 40.2. The PE Ratio of Retail industry is 164.1. The PE Ratio of Textiles industry is 35.8. In 2024.

Historical P/E Ratio of Gujarat Themis Biosyn Ltd

No data available

Company Fundamentals for Gujarat Themis Biosyn Ltd

No data available

Image

Gujarat Themis Biosyn Ltd

NSE: GUJTHEMIS

PRICE

347.05

-2.30 (-0.66%)

stock direction

Last updated: 19 Sep 10:25

Share price Over Time

1M

1Y

3Y

5Y

Monitoring Gujarat Themis Biosyn Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Share Price

Date
leftPriceleft
18 Sep 2024349.35
17 Sep 2024351.2
16 Sep 2024349.55
13 Sep 2024349
12 Sep 2024351.4
11 Sep 2024343.65
10 Sep 2024350.4
09 Sep 2024341.1
06 Sep 2024335.25
05 Sep 2024344.2

SWOT Analysis Of Gujarat Themis Biosyn Ltd

Strength

1

S

Weakness

0

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Gujarat Themis Biosyn Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Gujarat Themis Biosyn Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of P/E Ratio

Key Valuation Metric of Gujarat Themis Biosyn Ltd

No data available

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Gujarat Themis Biosyn Ltd

No data available

* All values are in crore

Historical Revenue of Gujarat Themis Biosyn Ltd

No data available

* All values are in crore

Historical EBITDA of Gujarat Themis Biosyn Ltd

No data available

* All values are in crore

Historical Net Profit of Gujarat Themis Biosyn Ltd

No data available

* All values are in crore

Historical Dividend Payout of Gujarat Themis Biosyn Ltd

No data available

* All values are in %

About Gujarat Themis Biosyn Ltd

  • Promoted by Kantilal Shah, Gujarat Themis Biosyn Limited was incorporated in 1981 as a joint sector company with Gujarat Industrial Investment Corporation Ltd (GIIC) and Chemosyn (P) Ltd. The Company commenced production in August 1985.
  • It was subsequently taken over in June 1991 by Yuhan Group, South Korea and Pharmaceutical Business Group (India) Ltd. (PBG); a unique consortium of five competing drug companies - Themis Medicare Ltd., Kopran Ltd., Anant & Co., Cadila Health Care Ltd. (Zydus) and Lyka Labs Ltd. It is being actively managed by Themis Medicare Ltd. (JV company of Gedeon Richter Ltd, Hungary) since 2007.
  • Initially manufacturing the antibiotic, erythromycin, GTBL obtained licences to manufacture bulk drugs like rifampicin, cephalexin, griseofulvin and their formulations in 1990.

Gujarat Themis Biosyn Ltd News Hub

News

Gujarat Themis' Q1 PAT falls over 25% YoY to Rs 13 crore

This decline was primarily driven by a 21.7% YoY drop in net sales to Rs 38.83 crore. Tota...

Read more

27 Jul 202409:25

News

Board of Gujarat Themis Biosyn appoints director

The Board of Gujarat Themis Biosyn has approved the appointment of K. G. Ananthakrishnan (...

Read more

26 Jul 202419:50

News

Gujarat Themis Biosyn schedules board meeting

Gujarat Themis Biosyn will hold a meeting of the Board of Directors of the Company on 26 J...

Read more

17 Jul 202410:09

News

Board of Gujarat Themis Biosyn recommends Final Dividend

Gujarat Themis Biosyn announced that the Board of Directors of the Company at its meeting ...

Read more

14 May 202415:48

News

Gujarat Themis Biosyn to convene AGM

Gujarat Themis Biosyn announced that the 43th Annual General Meeting(AGM) of the company w...

Read more

14 May 202417:12

News

Gujarat Themis Biosyn to convene board meeting

Gujarat Themis Biosyn will hold a meeting of the Board of Directors of the Company on 14 M...

Read more

03 May 202417:43

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

FAQs for PE of Gujarat Themis Biosyn Ltd

What is the current PE Ratio of Gujarat Themis Biosyn Ltd?

The Current PE Ratio of Gujarat Themis Biosyn Ltd is 69.59 as on 19 Sep 2024.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.2 as on 19 Sep 2024.

What was the PE Ratio of Gujarat Themis Biosyn Ltd last year?

The PE Ratio of Gujarat Themis Biosyn Ltd was 17.2 last year, now the PE ratio is 69.59, showing a year-on-year growth of 304.6%.

What does the PE Ratio of Gujarat Themis Biosyn Ltd indicate about its stock?

The PE Ratio of Gujarat Themis Biosyn Ltd is 69.59. This ratio indicates that investors are willing to pay 69.59 times the earnings per share for each share of Gujarat Themis Biosyn Ltd.

What is the PE Ratio Growth of Gujarat Themis Biosyn Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Gujarat Themis Biosyn Ltd grew by 304.6% whereas, the EPS ratio grew by -16.9.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*